A Phase 2 Study to Evaluate Safety and Efficacy of EB-001 Intramuscular (IM) Injections in Reducing Musculoskeletal Pain in Subjects Undergoing Elective Augmentation Mammoplasty (Breast Augmentation)
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2017
At a glance
- Drugs EB 001 (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Bonti
- 20 Jun 2017 Status changed from planning to not yet recruiting.
- 20 Apr 2017 New trial record
- 18 Apr 2017 According to a Bonti media release, company plans to initiate this study during the second half of 2017 and accelerate the generation of interim data by the end of the year.